185 related articles for article (PubMed ID: 25141900)
1. Parkinson's disease pharmacogenomics: new findings and perspectives.
Schumacher-Schuh AF; Rieder CR; Hutz MH
Pharmacogenomics; 2014 Jun; 15(9):1253-71. PubMed ID: 25141900
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease.
Kalinderi K; Fidani L; Katsarou Z; Bostantjopoulou S
Int J Clin Pract; 2011 Dec; 65(12):1289-94. PubMed ID: 22093536
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics-a New Frontier for Individualized Treatment of Parkinson's Disease.
Liu JS; Chen Y; Shi DD; Zhang BR; Pu JL
Curr Neuropharmacol; 2023; 21(3):536-546. PubMed ID: 36582064
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenetics in Parkinson's disease treatment].
Białecka M; Kłodowska-Duda G; Kurzawski M; Droździk M
Neurol Neurochir Pol; 2008; 42(2):131-8. PubMed ID: 18512170
[TBL] [Abstract][Full Text] [Related]
5. Novel insights in pharmacogenetics of drug response in Parkinson's disease.
Arbouw ME; Guchelaar HJ; Egberts TC
Pharmacogenomics; 2010 Feb; 11(2):127-9. PubMed ID: 20136351
[No Abstract] [Full Text] [Related]
6. The future of pharmacogenetics in Parkinson's disease treatment.
Hutz MH; Rieder CR
Pharmacogenomics; 2018 Feb; 19(3):171-174. PubMed ID: 29191064
[No Abstract] [Full Text] [Related]
7. Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.
Politi C; Ciccacci C; Novelli G; Borgiani P
Neuromolecular Med; 2018 Mar; 20(1):1-17. PubMed ID: 29305687
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of antiparkinsonian drug treatment: a systematic review.
Arbouw ME; van Vugt JP; Egberts TC; Guchelaar HJ
Pharmacogenomics; 2007 Feb; 8(2):159-76. PubMed ID: 17286539
[TBL] [Abstract][Full Text] [Related]
9. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough.
Lang AE; Obeso JA
Lancet Neurol; 2004 May; 3(5):309-16. PubMed ID: 15099546
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of motor symptoms in Parkinson's disease].
Morís-De la Tassa G; Arias-Rodríguez M
Rev Neurol; 2009 Jan; 48 Suppl 1():S27-31. PubMed ID: 19222012
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics of Alzheimer's and Parkinson's diseases.
Cacabelos R
Neurosci Lett; 2020 May; 726():133807. PubMed ID: 30236877
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in dopaminergic strategies for the treatment of Parkinson's disease.
Mao Q; Qin WZ; Zhang A; Ye N
Acta Pharmacol Sin; 2020 Apr; 41(4):471-482. PubMed ID: 32112042
[TBL] [Abstract][Full Text] [Related]
13. Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson's disease.
Faulkner MA
Expert Opin Drug Saf; 2014 Aug; 13(8):1055-69. PubMed ID: 24962891
[TBL] [Abstract][Full Text] [Related]
14. [Current therapeutic approach in Parkinson disease].
Przedborski S; Levivier M
Rev Med Brux; 1992 Dec; 13(10):360-6. PubMed ID: 1480887
[TBL] [Abstract][Full Text] [Related]
15. Levodopa in Parkinson's disease: from the past to the future.
Pezzoli G; Zini M
Expert Opin Pharmacother; 2010 Mar; 11(4):627-35. PubMed ID: 20163273
[TBL] [Abstract][Full Text] [Related]
16. New considerations in the medical management of early Parkinson's disease: impact of recent clinical trials on treatment strategy.
Hauser RA
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S17-21. PubMed ID: 20082983
[TBL] [Abstract][Full Text] [Related]
17. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
Klivényi P; Vécsei L
Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in pharmacological therapy of Parkinson's disease.
Riederer P; Lange KW; Youdim MB
Adv Neurol; 1993; 60():626-35. PubMed ID: 8093582
[TBL] [Abstract][Full Text] [Related]
19. Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems.
Brichta L; Greengard P; Flajolet M
Trends Neurosci; 2013 Sep; 36(9):543-54. PubMed ID: 23876424
[TBL] [Abstract][Full Text] [Related]
20. Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease.
Müller B; Assmus J; Larsen JP; Haugarvoll K; Skeie GO; Tysnes OB;
Acta Neurol Scand; 2013 Apr; 127(4):290-4. PubMed ID: 22998158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
